H.B. Fuller Company announced on October 8, 2026, that it has priced an offering of $850 million in aggregate principal amount of senior unsecured notes due 2034. The notes carry a coupon rate of 7.625% and are being issued at an issue price equal to 100% of their principal amount.
The debt offering is a private placement exempt from registration requirements under the Securities Act of 1933. The notes are being offered only to qualified institutional buyers under Rule 144A or to non-U.S. persons in compliance with Regulation S.
H.B. Fuller intends to use the net proceeds from this offering, combined with other available cash and borrowings, for several specific purposes. These include funding the purchase price for the acquisition of Advanced Medical Solutions Group plc, repaying borrowings under its Second Amended and Restated Credit Agreement, and redeeming H.B. Fuller’s 4.000% notes due February 15, 2027. The company also stated that proceeds will be used for other general corporate purposes.
The transaction is expected to close on or about October 21, 2026, subject to customary closing conditions. The company has included a provision in the offering terms regarding the acquisition of Advanced Medical Solutions Group plc. If the acquisition is not consummated on or before June 25, 2027, or if the company determines that a cooperation agreement with the target has been terminated, H.B. Fuller will be required to redeem $450 million of the notes at 100% of the initial issue price, plus accrued interest.
